Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
about
Bed rest for preventing complications after transfemoral cardiac catheterisation: a protocol of systematic review and network meta-analysisEffect of Pretreatment with Omega-3 Supplement on Cardiac Necrosis Markers in Chronic Kidney Disease Patients Undergoing Elective Percutaneous Coronary Intervention.Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.Third universal definition of myocardial infarction.Periprocedural hemoglobin changes and myocardial injury in patients undergoing percutaneous coronary interventionRelationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary InterventionHigh-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosisA Comparison of Peri-Procedural Myocardial Infarction between Paclitaxel-Coated Balloon and Drug-Eluting Stent on De Novo Coronary Lesions.Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Myocardial ischemia is a key factor in the management of stable coronary artery diseaseP2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal useEffect of High-Dose Statin Pretreatment on the Incidence of Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention: Grading the Evidence Through a Cumulative Meta-analysis.Predictive value of plaque morphology assessed by frequency-domain optical coherence tomography for impaired microvascular perfusion after elective stent implantation: the intracoronary electrocardiogram study.Remote Ischemic Conditioning in Elective PCI?Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: Overall outcomes and comparison between provisional and planned double stenting strategy.Intracoronary near-infrared spectroscopy: an overview of the technology, histologic validation, and clinical applications.Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trial.Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.Periprocedural type IVa myocardial infarction and the importance of platelet inhibition.Optical coherence tomography-based predictors for creatine kinase-myocardial band elevation after elective percutaneous coronary intervention for in-stent restenosis.Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).Third universal definition of myocardial infarctionDesign and Rationale for the Endothelin-1 Receptor Antagonism in the Prevention of Microvascular Injury in Patients with non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (ENDORA-PCI) Trial
P2860
Q28081881-0A75AAEB-9BFC-411D-953A-74B4324DABA5Q33777150-19EE0B2D-8A6F-4F82-879D-DA3757CCDDE9Q34282119-CBCD91CD-C060-46C2-8C7D-D804D2CC5D2DQ34295914-1D61BE23-94E3-4170-B02F-3640798FEEFEQ34621093-B2DBAD23-8C2E-4F69-BF0C-B93A1A205482Q34621168-6A121D81-B998-4D3C-8D10-8ACD65FBF9E6Q34634358-51B4FB08-D796-4ABD-BBD6-21ABE8A502B9Q36649949-05922019-DF59-4400-A4FC-4D5C3EE1AE6DQ37438436-7A51BC0C-E537-4DD9-B97F-32B8B25C5F04Q37472971-BE0629FE-D457-4699-AB3E-726BDE0C0BB3Q37722766-FCC1B99D-A6F0-4339-B5BD-9FD0141B5670Q38542096-47C22D94-5884-46B2-830A-8ECE7AFE5BE2Q38600680-AB34BA9E-143E-41F9-A650-F11E76C0F878Q38741567-E2E2BA12-830E-4838-9DD7-5417778204FAQ39219871-4514708A-16C0-4FC3-A0B8-B6D372CCAEF2Q39680106-A85CDD24-EB76-4FB3-B153-4A53072A2CDEQ40899680-90530F0C-64EA-4D58-986E-F1C96F22ED96Q42378581-ADA2CCF3-6B39-4520-B286-27A1A306C296Q45093548-1A68ED4A-5DB3-4848-8F94-F7646FCA5CACQ45839848-483DB28E-9427-43F7-9D73-1CD35249FF52Q47268781-A19FE5AF-A28F-4DA9-B0BB-E8D6C93E40C4Q48337919-5A19C648-9692-4237-8EFC-3245ADDFEF85Q51065348-0AF2951A-B471-4137-861D-F10F19A7948BQ53464604-34CD797C-1809-4D48-8193-664E57D63FB4Q54980932-D0A29151-60EA-4429-8BBA-4806E6E17250Q57314061-0CC15742-6AC5-467B-AA35-DD65BC5C6CC4Q57808339-C8C5515E-43E9-43D0-BE08-EAD075FDE6D9
P2860
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@ast
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en-gb
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@nl
type
label
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@ast
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en-gb
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@nl
altLabel
Periprocedural myocardial infarction: prevalence, prognosis, and prevention
@en
prefLabel
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@ast
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en-gb
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@nl
P1476
Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention
@en
P2093
A. J. Lansky
G. W. Stone
P304
P356
10.1161/CIRCINTERVENTIONS.110.959080
P407
P577
2010-12-01T00:00:00Z